Daymark Wealth Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Daymark Wealth Partners's AMGN Position: Q2 2026 in Review
Daymark Wealth Partners reduced its Amgen (AMGN) stake by 0.05% in Q2 2026, selling an estimated $23.3K and leaving 150,438 shares worth $54.5M. The position accounts for 1.33% of the portfolio, ranked #13.
Daymark Wealth Partners first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. 3,148 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Daymark Wealth Partners held 150,438 shares of Amgen worth $54.5M as of Q2 2026.
- Daymark Wealth Partners sold 68 Amgen shares in Q2 2026, an estimated $23.3K.
- Amgen made up 1.33% of Daymark Wealth Partners's portfolio in Q2 2026, its #13 holding.
- Daymark Wealth Partners first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
- 3,148 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Daymark Wealth Partners's 13F filing for Q2 2026, filed 31 Jul 2026.